| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 05/21/2004 | WO2004042351A2 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004041817A1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 05/21/2004 | WO2004041783A1 Process for preparation of carvedilol |
| 05/21/2004 | WO2004041782A1 Indoles useful in the treatment of androgen-receptor related diseases |
| 05/21/2004 | WO2004041781A1 Preparation of 3-aminoalkyl-substituted indole derivatives from phenylhydrazines and aminoketones |
| 05/21/2004 | WO2004041780A2 N-(indole-2-carbonyl) amides as anti-diabetic agents |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004041264A1 2-oxo-ethanesulfonamide derivates |
| 05/21/2004 | WO2004005406A3 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 05/21/2004 | WO2004004629A3 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/21/2004 | CA2503844A1 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2503727A1 Anti-diabetic agents |
| 05/20/2004 | US20040097725 Charge transport compositions and electronic devices made with such compositions |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097576 Use of tryptophane-derivatives, that are toxicated into specific toxins in body's cell by enzymes tryptophan-hydroxylase and aromatic amino acid decarboxylase of body, for simultaneous reduction and/or disruption of serotonin |
| 05/20/2004 | US20040097574 For therapy of inflammatory, allergic, or proliferative processes |
| 05/20/2004 | US20040097540 Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 05/20/2004 | US20040097532 3-Substituted oxindole beta 3 agonists |
| 05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
| 05/20/2004 | US20040097422 Methods of use for tripeptidyl peptidase II inhibitors as anticancer agents |
| 05/20/2004 | US20040096397 Sulfonated diarylrhodamine dyes |
| 05/19/2004 | EP1419126A1 Fluorous nucleophilic substitution of alcohols and reagents for use therein |
| 05/19/2004 | EP1418910A1 Methods for inhibiting or reversing tau filament formation polymerization |
| 05/19/2004 | EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 05/19/2004 | EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1202956B1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same |
| 05/19/2004 | EP1140824B1 Method for producing 3-alkanoylindoles and 3-alkylindoles |
| 05/19/2004 | EP1131308B1 New piperazine and piperidine compounds |
| 05/19/2004 | EP1047664B1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions |
| 05/19/2004 | DE10250743A1 Neue Amid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New amide compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498214A Bicyclic guanidine derivatives and therapeutic uses thereof |
| 05/19/2004 | CN1498209A 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/19/2004 | CN1497360A Organic photoreceptor with compound containing toluidine group |
| 05/19/2004 | CN1497006A Preparation method of poly (diimide ether) |
| 05/19/2004 | CN1496999A Solid phase synthesing method of aldehyde, ketonic, oxime amine and isohydroximic acid compound |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1496980A N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action |
| 05/19/2004 | CN1150167C Indole derivatives |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/18/2004 | US6737533 Pigmented vitreous material |
| 05/18/2004 | US6737532 High efficiency blue and green emitters; benzimidazole, benzoxazole, benzthiazole and/or indole derivatives |
| 05/18/2004 | US6737435 Indole derivatives and their use as MCP-1 antagonist |
| 05/18/2004 | US6736862 Indole/indoline based hybrid dyes and indole/indoline based hybrid dye intermediate products |
| 05/18/2004 | CA2297279C New cyano-indole compounds that inhibit serotonin recapture, the process for their preparation and the pharmaceutical compounds that contain them |
| 05/18/2004 | CA2214759C Intimal hypertrophy inhibitors |
| 05/13/2004 | WO2004039894A2 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 05/13/2004 | WO2004039797A1 A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancer |
| 05/13/2004 | WO2004039795A2 Amide compounds for the treatment of hyperlipidemia |
| 05/13/2004 | WO2004039777A1 Process for producing optically active hydroxylactam compound |
| 05/13/2004 | WO2004039764A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 05/13/2004 | WO2004039314A2 Process for synthesizing l-y-methylene glutamic acid and analogs |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | US20040092750 2-methylindole-4-acetic acid, process for producing the same, and process for producing intermediate therefor |
| 05/13/2004 | US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092564 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092507 Melanocortin receptor agonists |
| 05/13/2004 | US20040092506 Administering estrogen antagonist; skin disorders; wrinkle resistance; antiarthritic agents; anticancer agents; wound healing agents |
| 05/13/2004 | US20040092502 Central nervous system disorders; dietetics; psychological disorders; sleep disorders; sexual disorders |
| 05/13/2004 | US20040092495 Hypoglycemic agents; antidiabetic agents |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/13/2004 | CA2484218A1 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1417031A1 Amine elimination process for making single-site catalysts |
| 05/12/2004 | EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 05/12/2004 | EP1341785A4 HYDROLYSIS OF R(R*,R*)]-2-(4-FLUOROPHENYL)-$g(b),$g(d) -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- (PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE |
| 05/12/2004 | EP1242375B1 Method for purifying lactames |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | EP1015429B1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 05/12/2004 | CN1496350A Improved process for preparing pure ondansetron hydrochloride dihydrate |
| 05/12/2004 | CN1496349A (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane, compositions and uses thereof |
| 05/12/2004 | CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors |
| 05/12/2004 | CN1496347A Biguanide derivatives |
| 05/12/2004 | CN1495188A Substituted tetrels metal complex, catalyst and olefin polymerization method |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1495165A Indane or indoline derivative |
| 05/12/2004 | CN1149213C Substituted benzoylisoxazoles and the use thereof as herbicides |
| 05/12/2004 | CN1149194C Process for preparation of spiro [(4-cyclohexanone)-[3H]indol]-2'[ih]-one derivs. |
| 05/12/2004 | CN1149193C Substituted tricyclic compound |
| 05/12/2004 | CN1149081C Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
| 05/11/2004 | US6734301 2,3,4,5-Tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds |
| 05/11/2004 | US6734205 Substituted guanidine derivatives |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6733883 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions |
| 05/11/2004 | US6733744 Indole compounds as minimally invasive physiological function monitoring agents |
| 05/06/2004 | WO2004037820A1 Oxindole substituted piperazine derivatives |
| 05/06/2004 | WO2004037805A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037788A1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases |
| 05/06/2004 | WO2004037251A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 05/06/2004 | WO2004037247A1 Oxindoles with anti-hiv activity |
| 05/06/2004 | WO2004037181A2 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods |
| 05/06/2004 | WO2004022524A3 N-vinylformamide derivatives, polymers formed therefrom and synthesis thereof |